Evidence map›Paper›PMID 23838256›Full record

ReviewEnvironmental health perspectives2013

Human Health Risk Assessment (HHRA) for environmental development and transfer of antibiotic resistance.

Nicholas J Ashbolt, Alejandro Amézquita, Thomas Backhaus, Peter Borriello, Kristian K Brandt, Peter Collignon, Anja Coors, Rita Finley, William H Gaze, Thomas Heberer and 9 more

Abstract readReview
In one paragraph

Review in Environmental health perspectives, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 162 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
162citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

162 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. City or Suburb, Resistance Flows: Wastewater-BorneAntibiotics (Basel, Switzerland) · 2025
    Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Agriculturally Sourced Multidrug-ResistantPathogens (Basel, Switzerland) · 2025
    Article

102 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Nicholas J AshboltUS Environmental Protection Agency, Office of Research and Development, Cincinnati, Ohio 45268, USA. Ashbolt.Nick@epa.gov
Alejandro Amézquita
Thomas Backhaus
Peter Borriello
Kristian K Brandt
Peter Collignon
Anja Coors
Rita Finley
William H Gaze
Thomas Heberer
John R Lawrence
D G Joakim Larsson
Scott A McEwen
James J Ryan
Jens Schönfeld
Peter Silley
Jason R Snape
Christel Van den Eede
Edward Topp

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOnly recently has the environment been clearly implicated in the risk of antibiotic resistance to clinical outcome, but to date there have been few documented approaches to formally assess these risks.

objectiveWe examined possible approaches and sought to identify research needs to enable human health risk assessments (HHRA) that focus on the role of the environment in the failure of antibiotic treatment caused by antibiotic-resistant pathogens.

methodsThe authors participated in a workshop held 4-8 March 2012 in Québec, Canada, to define the scope and objectives of an environmental assessment of antibiotic-resistance risks to human health. We focused on key elements of environmental-resistance-development "hot spots," exposure assessment (unrelated to food), and dose response to characterize risks that may improve antibiotic-resistance management options. DISCUSSION: Various novel aspects to traditional risk assessments were identified to enable an assessment of environmental antibiotic resistance. These include a) accounting for an added selective pressure on the environmental resistome that, over time, allows for development of antibiotic-resistant bacteria (ARB); b) identifying and describing rates of horizontal gene transfer (HGT) in the relevant environmental "hot spot" compartments; and c) modifying traditional dose-response approaches to address doses of ARB for various health outcomes and pathways.

conclusionsWe propose that environmental aspects of antibiotic-resistance development be included in the processes of any HHRA addressing ARB. Because of limited available data, a multicriteria decision analysis approach would be a useful way to undertake an HHRA of environmental antibiotic resistance that informs risk managers.

Indexed as

Drug Resistance, MicrobialEnvironmentHealth Status IndicatorsDose-Response Relationship, DrugEducationHumansModels, TheoreticalRisk Assessment

Identifiers

PMID23838256
PMCPMC3764079

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.